Optimising antidepressant use in clinical practice: Towards criteria for antidepressant selection

British Journal of Psychiatry

Volumn 179, Issue SUPPL. 42, 2001, Pages

  Mendlewicz, J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PRACTICE; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; ECONOMIC ASPECT; HEALTH CARE SYSTEM; HUMAN; ECONOMICS; HEALTH CARE COST; PATIENT COMPLIANCE; PRACTICE GUIDELINE; REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HEALTH CARE COSTS; HUMANS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 0034855879     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.179.42.s1     Document Type: Article

References (34)

1. Treatment of Major Depression
2. The efficacy of selective serotonin reuptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants
3. Guidelines for treating depressive illness with antidepressants
4. Partial medication compliance: The enigma in poor medical outcomes
5. Compliance during treatment with antidepressants
6. Noncompliance with antidepressants: Who's to blame?
7. Selective serotonin reuptake inhibitor use in primary care: A five year naturalistic study
8. The treatment of depression: Prescribing patterns of antidepressants in primary care in the UK
9. Patient noncompliance: Deviance of reasoned decision-making
10. Selective serotonin reuptake inhibitor antidepressant prescribing in primary care in the United Kingdom
11. Compliance: Definitions and key issues
12. The economic burden of depression in 1990
13. Depression: A neglected major illness
14. Outpatient drug utilization in a Dutch Sick Fund
15. Adequacy and duration of antidepressant treatment in primary care
16. Collaborative management to achieve treatment guidelines: Impact on depression in primary care
17. Prescribing patterns of antidepressant medications for depression in an HMO
18. The cost of depression
19. Physical symptoms in primary care: Predictors of psychiatric disorders and functional impairment
20. Depression in the community: The first pan-European study DEPRES (Depression Research in European Society)
21. Treatment of depression: Prescription for success?
22. The defeat depression campaign: Psychiatry in the public arena
23. Continuation drug therapy for major depressive disorder: How long should it be maintained?
24. Improving the management and knowledge of depression
25. Lay people's attitudes to treatment of depression: Results of opinion poll for defeat depression campaign just before its launch
26. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: A prescription database study
27. Recognition and management of depression in general practice
28. Utilization of health and mental health services: Three epidemiological catchment area sites
29. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study
30. Health care costs associated with depressive and anxiety disorders in primary care
31. The functioning and well-being of depressed patients: Results from the medical outcomes study
32. Detection of depressive disorder for patients receiving prepaid or fee-for-service: Results from the medical outcomes study
33. Pharmacotherapy of depressive disorders: WHO consensus statement